Trinity Guardion Launches Second-Generation Protective Patient Barrier at APIC 2017

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Trinity Guardion will unveil the newest version of its protective patient barrier system for hospital mattresses, to infection preventionists and other stakeholders attending the Association of Professionals in Infection Control (APIC) 2017 Annual Conference in Portland, Oregon. The system and its three new enhancements will be exhibited and discussed at Booth #266, from June 14 to 16.

Trinity Guardion’s patient protection barrier system is already in use in forward-thinking U. S. healthcare facilities. It includes a microbarrier for the mattress and bed deck, and a separate pillow barrier, and is the first and only launderable mattress microbarrier system specifically for medical beds. It’s designed to protect each patient (and prolong the useful life of each mattress) by shielding the mattress and bed deck from every previous occupant’s microbial biome, and specifically from pathogenic organisms such as Clostridium difficile (C. diff), which can cause serious illness and death. The Trinity Guardion system can stand up to repeated high-heat laundering with chlorine bleach to inactivate spores.

Infection preventionists (IPs) and environmental services professionals (EVS) face unremitting infection prevention challenges. In many hospitals, IPs and EVS teams work together to design programs with the goal of consistently preventing healthcare-acquired infections, which cause significant suffering and are a financial burden to patients and healthcare facilities. They must address all major sources of infection, including the risks from room surfaces such as patient beds. Ironically, although beds serve as the epicenter of patient care, they have also been shown to be an epicenter of potential cross-contamination, for a multitude of reasons.

Enhanced features
At the APIC exhibit, three improvements to the Trinity Guardion system will be discussed.
1.    The textile is now launderable up to 150 times (formerly up to 100 times).
2.    The improved textile has an even higher moisture vapor transfer rate, which helps protect against skin maceration and breakdown.
3.    Each system now comes with a unique identifier barcode, which facilitates tracking documentation, per CMS requirements.

“After listening to the needs of infection preventionists and environmental services professionals, and investigating new regulatory requirements for care providers, we’ve developed an improved system with features that further enhance infection prevention programs while simplifying the bed turnover process,” said Bruce Rippe, CEO and co-founder of Trinity Guardion. “What better moment to launch this improved technology than at the APIC Conference this year.”



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles